Pigmented Lesion Treatment Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 3.37 Billion |
| Market Size (2029) | USD 4.69 Billion |
| CAGR (2024 - 2029) | 6.80 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Pigmented Lesion Treatment Market Analysis
The Pigmented Lesion Treatment Market size is estimated at USD 3.37 billion in 2024, and is expected to reach USD 4.69 billion by 2029, growing at a CAGR of 6.80% during the forecast period (2024-2029).
The market for pigmented lesion treatments is witnessing robust growth, driven by several key factors. These include a rising prevalence of pigmentation lesions, heightened public awareness about skin treatments, the introduction of new products, and the establishment of specialized dermatology clinics.
An article from the August 2022 issue of Dermatological Review highlighted melasma as a prevalent form of acquired hyperpigmentation. It emphasized that this condition affected millions globally, with a notably higher incidence in women.
As research into pigmentation lesion diagnosis intensifies, the demand for treatment rises, subsequently fueling the need for specialized devices. This, in turn, could boost market growth.
In February 2022, GMV and the Biomedical Research Foundation of Madrid’s Hospital Universitario La Paz (FIBHULP) initiated the DALEM project. This project focuses on leveraging space technology to monitor pigmented skin lesions. Such collaborations, seen globally, offer enhanced monitoring capabilities, ultimately leading to more effective treatments.
Product innovation is also a significant driver. In October 2023, Rohrer Aesthetics, a prominent medical aesthetic device manufacturer, unveiled 'Symmetry.' This laser treatment, the first of its kind cleared by the FDA for hand rejuvenation, boasts SwiftScan Intelligent Technology. This technology ensures precise energy delivery, effectively addressing pigmented lesions, uneven pigmentation, brown spots, and other age-related skin concerns.
While the market is poised for growth, owing to the rising prevalence of pigmented lesions and innovative product launches, it is crucial to note that potential side effects from treatments could pose challenges to this growth trajectory.
Pigmented Lesion Treatment Market Trends
Lasers and Energy-based Devices are Expected to Witness Significant Growth
Laser and energy-based devices are gaining traction, driven by their advantages, patient preferences, and the introduction of new products by market players.
An article in Statpearls, updated in July 2024, highlighted that laser devices, known for their minimally invasive nature and high efficacy, are becoming the go-to therapeutic choice for patients with pigmented lesions. Such findings, showcasing the benefits of these devices, are pivotal in boosting their adoption rates and subsequently fueling market growth.
The prevalence of pigmented lesions underscores the demand for treatment devices. A study published in the Journal of Stomatology and Oral and Maxillofacial Surgery in September 2022 revealed that 20.8% of the population had oral pigmentation. Notably, the study emphasized a higher prevalence of oral pigmentation among male smokers and those exposed to cigarette smoke, further underscoring the necessity for laser and energy-based devices.
Global regulatory approvals play a significant role in the market's expansion. For instance, in June 2022, Cynosure unveiled the PicoSure Pro device in the US. This device, featuring a 755 nm picosecond laser, was among the first of its kind to receive FDA clearance. The PicoSure Pro stands out for its unique energy delivery. It operates in a trillionth of a second and relies on pressure, rather than heat, for safe and effective pigmentation treatments and skin revitalization across all skin types.
Given the rising importance of energy-based devices in treating pigmented lesions and the surge in new product launches, this segment is poised for robust growth in the coming years.
North America is Expected to Dominate the Market Over the Forecast Period
North America leads the global pigmented lesions treatment market, driven by a surge in pigmentation disorders. The region's robust healthcare infrastructure, coupled with the presence of key market players, ensures effective treatment options.
Additionally, the initiatives taken for the screening of pigmented lesions and approvals from regulatory authorities boost market growth in the region.
Regulatory approvals play a pivotal role in shaping the market landscape. For instance, in March 2023, Candela Corporation garnered clearances from both the US FDA and Health Canada for its PicoWay laser system, which was expanded to treat even the challenging melasma condition. Such approvals introduce new products and fuel market growth in the US and Canada.
Regional initiatives focusing on pigmented lesion screenings enhance disease awareness and underline the necessity for treatments. For example, in April 2023, MedX Health Corp. signed an MoU with PharmaChoice Canada. This collaboration aimed to roll out MedX’s DermSecure Screening Platform across all PharmaChoice pharmacies, enabling swift dermatological assessments for pigmented lesions, moles, and other skin conditions.
Thus, factors such as heightened screenings, product approvals, and the establishment of dermatological clinics are driving the market’s growth in the region.
Pigmented Lesion Treatment Market Overview
The global pigmented lesion treatment market is semi-consolidated and has a few major players. Companies like Alma Lasers Ltd, Cutera Inc., Cynosure Inc., Lumenis Ltd, Lutronic Corporation, Lynton Lasers Ltd, Solta Medical Inc., Strata Skin Sciences Inc., and Syneron Medical Ltd hold a substantial share in the market.
Pigmented Lesion Treatment Market Leaders
-
Alma Lasers Ltd.
-
Lumenis Ltd.
-
Cynosure, Inc.
-
Strata Skin Sciences Inc.
-
Solta Medical Inc.
*Disclaimer: Major Players sorted in no particular order
Pigmented Lesion Treatment Market News
- May 2024: Acclaro Medical secured FDA clearance for its UltraClear cold ablative fractional 2,910 nm fiber laser. This clearance allows the laser to be used specifically in treating benign pigmented lesions and vascular dyschromia.
- March 2024: Reveal Lasers LLC unveiled its latest innovation, the AlloraPro Laser Workstation. This cutting-edge device is designed to effectively target a range of skin concerns, from vascular lesions like leg and facial veins to pigmented lesions and photorejuvenation treatments.
Pigmented Lesion Treatment Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Geriatric Population
- 4.2.2 Increasing Prevalence of Pigmentation Disorders
-
4.3 Market Restraints
- 4.3.1 Side Effects Associated with Certain Treatments
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Bargaining Power of Buyers/Consumers
- 4.4.2 Bargaining Power of Suppliers
- 4.4.3 Threat of New Entrants
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 By Product Type
- 5.1.1 Lasers and Energy Based Devices
- 5.1.2 RF Devices
- 5.1.3 Ultrasound Devices
- 5.1.4 Other Product Types
-
5.2 By End User
- 5.2.1 Dermatology Clinics
- 5.2.2 Beauty Clinics
- 5.2.3 Other End Users
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Alma Lasers Ltd
- 6.1.2 Cutera Inc.
- 6.1.3 Cynosure Inc.
- 6.1.4 Lumenis Ltd
- 6.1.5 Lutronic Corporation
- 6.1.6 Lynton Lasers Ltd
- 6.1.7 Solta Medical Inc.
- 6.1.8 Strata Skin Sciences Inc.
- 6.1.9 Syneron Medical Ltd
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityPigmented Lesion Treatment Industry Segmentation
As per the report's scope, pigmented lesions refer to brown or black skin spots, moles, age spots, and sun-damaged skin. Pigmented skin lesions are majorly melanocytic. However, non-melanocytic lesions can also be pigmented, specifically in dark-skinned individuals. Treatment of such disorders includes laser and energy-based devices and ultrasound devices.
The pigmented lesion treatment market is segmented by product type, end user, and geography. By product type, the market is sub-segmented into lasers and energy-based devices, RF devices, ultrasound devices, and other product types. By end user, the market is sub-segmented into dermatology clinics, beauty clinics, and other end users. By geography, the market is sub-segmented into North America, Europe, Asia-Pacific, the Middle East, Africa, and South America. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (USD) for all the above segments.
| By Product Type | Lasers and Energy Based Devices | |
| RF Devices | ||
| Ultrasound Devices | ||
| Other Product Types | ||
| By End User | Dermatology Clinics | |
| Beauty Clinics | ||
| Other End Users | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Pigmented Lesion Treatment Market Research FAQs
How big is the Pigmented Lesion Treatment Market?
The Pigmented Lesion Treatment Market size is expected to reach USD 3.37 billion in 2024 and grow at a CAGR of 6.80% to reach USD 4.69 billion by 2029.
What is the current Pigmented Lesion Treatment Market size?
In 2024, the Pigmented Lesion Treatment Market size is expected to reach USD 3.37 billion.
Who are the key players in Pigmented Lesion Treatment Market?
Alma Lasers Ltd., Lumenis Ltd., Cynosure, Inc., Strata Skin Sciences Inc. and Solta Medical Inc. are the major companies operating in the Pigmented Lesion Treatment Market.
Which is the fastest growing region in Pigmented Lesion Treatment Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Pigmented Lesion Treatment Market?
In 2024, the North America accounts for the largest market share in Pigmented Lesion Treatment Market.
What years does this Pigmented Lesion Treatment Market cover, and what was the market size in 2023?
In 2023, the Pigmented Lesion Treatment Market size was estimated at USD 3.14 billion. The report covers the Pigmented Lesion Treatment Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Pigmented Lesion Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Pigmented Lesion Treatment Industry Report
Statistics for the 2023 Pigmented Lesion Treatment market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Pigmented Lesion Treatment analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
